The PE Ratio as of December 2024 (TTM) for Solid Biosciences Inc. (SLDB) is -1.37

According to Solid Biosciences Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.37. This represents a change of -51.02% compared to the average of -2.80 of the last 4 quarters.

Solid Biosciences Inc. (SLDB) Historical PE Ratio (quarterly & annually)

How has SLDB PE Ratio performed in the past?

The mean historical PE Ratio of Solid Biosciences Inc. over the last ten years is -13.87. The current -1.37 PE Ratio has changed 887.93% with respect to the historical average. Over the past ten years (40 quarters), SLDB's PE Ratio was at its highest in in the December 2022 quarter at 2.35. The PE Ratio was at its lowest in in the March 2016 quarter at -70.35.

Solid Biosciences Inc. (SLDB) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Solid Biosciences Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Solid Biosciences Inc. (SLDB) Average PE Ratio

How has SLDB PE Ratio performed in the past?

The current PE Ratio of Solid Biosciences Inc. (SLDB) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Solid Biosciences Inc. (SLDB) PE Ratio vs. Peers

How is SLDB’s PE Ratio compared to its peers?

Solid Biosciences Inc.’s PE Ratio is less than Century Therapeutics, Inc. (-0.67), greater than Edgewise Therapeutics, Inc. (-22.36), greater than C4 Therapeutics, Inc. (-2.55), greater than Mineralys Therapeutics, Inc. (-4.16), greater than Cullinan Oncology, Inc. (-4.99), less than TCR2 Therapeutics Inc. (-0.38), greater than Revolution Medicines, Inc. (-13.06), greater than Black Diamond Therapeutics, Inc. (-1.69), less than Atreca, Inc. (-0.06), less than Passage Bio, Inc. (-0.58), greater than Anebulo Pharmaceuticals, Inc. (-5.30), greater than Acrivon Therapeutics, Inc. Common Stock (-3.08), greater than PMV Pharmaceuticals, Inc. (-1.47), greater than Molecular Partners AG (-2.46), less than Stoke Therapeutics, Inc. (0), greater than Monte Rosa Therapeutics, Inc. (-6.05), greater than Cabaletta Bio, Inc. (-4.84), less than Larimar Therapeutics, Inc. (-1.10), greater than Alector, Inc. (-3.72), less than null (-1.13),

Build a custom stock screener for Solid Biosciences Inc. (SLDB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Solid Biosciences Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Solid Biosciences Inc. (SLDB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Solid Biosciences Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.